The first trial on humans for ‘reverse-aging’, one of the most important goals of medical science, has started. It is claimed that for the first time an injection that reverses the effects of age has been administered to a human being. This is being considered a major turning point in longevity science. America’s Boston-based biotech startup ‘Life Biosciences’ said that its first patient has been given the injection of cellular reprogramming. Under the test, this injection has been injected into the pupil of one eye of a patient suffering from glaucoma. The main objective of this test is to make the cells that have become weak due to aging young and active again. Scientists will keep an eye on its effects and side effects for the next 6 months. Earlier, successful tests have been done on rats and monkeys. In the first phase of this experiment, this experimental gene therapy has been injected directly into one eye of a patient suffering from glaucoma. Now doctors and scientists will monitor the patient closely for the coming several months to ensure whether this technology is completely safe for the human body or not. In this therapy, first a single gene therapy injection is given in the patient’s eye. After this, a special course of antibiotics is given for a few weeks. This antibiotic drug, once inside the body, acts as an ‘on switch’ for three treatment genes that begin to reprogram (rejuvenate) the cells. Earlier, in tests conducted on rats and monkeys, it had successfully restored their vision. The human eye has been chosen for this therapy because the eye is separate and safe from the rest of the body. This also makes it easier to monitor side effects. If the trial is successful, a new era of aging therapy. Life Biosciences CEO Jerry McLaughlin said that this is a potentially huge and transformative moment not only for his company or aging biology, but for the entire medical science. If this clinical trial is successful, a new era in aging therapy may begin. The goal is to rejuvenate and activate cells throughout the body by improving the way DNA functions and is expressed as we age. Investment by billionaires and pharma companies: Many big investors including Amazon founder Jeff Bezos and OpenAI’s Sam Altman have invested money in this technology. Pharmaceutical companies like Eli Lilly and Merck are also increasing investment in this idea. Before trials on humans, this research was limited to rats and monkeys. ————- Also read these news… Russia is developing technology to prevent aging: Work continues on growing human organs inside pigs, anti-aging project worth ₹ 2.47 lakh crore. Russian President Vladimir Putin has started a big government project worth 26 billion dollars i.e. about 2.47 lakh crore rupees to stop the increasing age and weakness of the body. In this program named ‘New Health Preservation Technologies’, work will be done on technologies like growing human organs inside special species of pigs. Read full news… ‘Gene Clock’ will tell at what age life will stop: Research claims – Knowing age from gene activity is more effective than old methods. Scientists have prepared a ‘molecular clock’ (molecular clock), which can predict the actual biological age of humans and even the possible time of their death on the basis of their gene activity. Read the full news…
Source link
[ad_3]
उम्र रोकने की दवा के पहली बार इंसान पर परीक्षण: ग्लूकोमा से पीड़ित एक मरीज की एक आंख की पुतली में लगाया गया इंजेक्शन
